Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol in Elderly Patients
NCT05201300Completed
- Sponsor
- Ajou University School of Medicine
- Start
- Feb 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial of remimazolam (3 arms), sponsored by Ajou University School of Medicine. Primary endpoint: Mean Arterial Pressure decrease. Started Feb 2022; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT05201300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05201300.